EP2190870A4 - Cell marker of melanocyte cell lineage and uses thereof - Google Patents

Cell marker of melanocyte cell lineage and uses thereof

Info

Publication number
EP2190870A4
EP2190870A4 EP08828507A EP08828507A EP2190870A4 EP 2190870 A4 EP2190870 A4 EP 2190870A4 EP 08828507 A EP08828507 A EP 08828507A EP 08828507 A EP08828507 A EP 08828507A EP 2190870 A4 EP2190870 A4 EP 2190870A4
Authority
EP
European Patent Office
Prior art keywords
cell
melanocyte
lineage
marker
cell marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08828507A
Other languages
German (de)
French (fr)
Other versions
EP2190870A1 (en
Inventor
Peter Roderick Dunbar
Oliver Horlacher
Vaughan John Feisst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Auckland Uniservices Ltd
Original Assignee
Auckland Uniservices Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auckland Uniservices Ltd filed Critical Auckland Uniservices Ltd
Publication of EP2190870A1 publication Critical patent/EP2190870A1/en
Publication of EP2190870A4 publication Critical patent/EP2190870A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP08828507A 2007-08-28 2008-08-28 Cell marker of melanocyte cell lineage and uses thereof Withdrawn EP2190870A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ56097707 2007-08-28
PCT/NZ2008/000223 WO2009028968A1 (en) 2007-08-28 2008-08-28 Cell marker of melanocyte cell lineage and uses thereof

Publications (2)

Publication Number Publication Date
EP2190870A1 EP2190870A1 (en) 2010-06-02
EP2190870A4 true EP2190870A4 (en) 2010-12-01

Family

ID=40387522

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08828507A Withdrawn EP2190870A4 (en) 2007-08-28 2008-08-28 Cell marker of melanocyte cell lineage and uses thereof

Country Status (3)

Country Link
EP (1) EP2190870A4 (en)
AU (1) AU2008293138A1 (en)
WO (1) WO2009028968A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010098682A1 (en) * 2009-02-27 2010-09-02 Auckland Uniservices Limited Cell marker for melanocyte lineage and cancer cells and uses thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000874A2 (en) * 1999-06-30 2001-01-04 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
WO2001079556A2 (en) * 2000-04-14 2001-10-25 Millennium Pharmaceuticals, Inc. Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers
WO2002064626A2 (en) * 2000-10-27 2002-08-22 Pe Corporation (Ny) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
WO2004093804A2 (en) * 2003-04-18 2004-11-04 Five Prime Therapeutics, Inc. Human polypeptides encoded by polynucleotides and methods of their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1254846A (en) * 1982-11-30 1989-05-30 Anthony Albino Monoclonal antibodies against melanocytes and melanomas
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
DE10238298A1 (en) * 2002-08-21 2004-03-04 Beiersdorf Ag Use of antisense oligonucleotides for the treatment of degenerative skin symptoms
DK1530636T3 (en) * 2002-08-21 2010-11-29 Univ British Columbia Treatment of melanomas by reducing the clusterin level
AU2005300688B2 (en) * 2004-11-03 2012-02-02 Almac Diagnostics Limited Transcriptome microarray technology and methods of using the same
US20070161031A1 (en) * 2005-12-16 2007-07-12 The Board Of Trustees Of The Leland Stanford Junior University Functional arrays for high throughput characterization of gene expression regulatory elements

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000874A2 (en) * 1999-06-30 2001-01-04 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
WO2001079556A2 (en) * 2000-04-14 2001-10-25 Millennium Pharmaceuticals, Inc. Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers
WO2002064626A2 (en) * 2000-10-27 2002-08-22 Pe Corporation (Ny) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
WO2004093804A2 (en) * 2003-04-18 2004-11-04 Five Prime Therapeutics, Inc. Human polypeptides encoded by polynucleotides and methods of their use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2009028968A1 *

Also Published As

Publication number Publication date
WO2009028968A8 (en) 2009-05-22
WO2009028968A1 (en) 2009-03-05
EP2190870A1 (en) 2010-06-02
AU2008293138A1 (en) 2009-03-05

Similar Documents

Publication Publication Date Title
IL267138A (en) Improved cell composition and methods of making the same
EP2195346A4 (en) Dendritic cell marker and uses thereof
ZA201000436B (en) Novel esterases and their use
ZA200908904B (en) Multipotent/pluripotent cells and methods
HK1147254A1 (en) 5-anilinoimidazopyridines and methods of use 5-
IL199836A (en) Isolated human cancer stem cells and uses thereof
IL205571A0 (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin
EP2173822A4 (en) Ink formulations and methods of making ink formulations
IL206125A0 (en) Azaindolizines and methods of use
EP2227540A4 (en) De-differentiation of human cells
EP2120952A4 (en) Antiviral compounds and methods of using thereof
GB2448589B (en) High Altitude structures and related methods
EP2170988A4 (en) Polystyrene compositions and methods of making and using same
EP2133326A4 (en) Novel pseudoglycolipid and use thereof
ZA201004894B (en) Nuctraceutical composition and methods of use
EP2190870A4 (en) Cell marker of melanocyte cell lineage and uses thereof
TWI367094B (en) 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands
GB2459413A8 (en) Perfluoroparacyclophane and methods of synthesis and use thereof
ZA201004893B (en) Nuctraceutical composition and methods of use
EP2205971A4 (en) Markers of endothelial cells and uses thereof
EP2185685A4 (en) Novel methods and cell lines
PL383157A1 (en) The manner of obtaining monochloropropandiols and dichloropropanols
GB0716515D0 (en) Regionalised endoderm cells and uses thereof
GB0809852D0 (en) Regionalised endoderm cells and uses thereof
AU2007905437A0 (en) Markers of Endothelial Cells and Uses Thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100324

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20101029

DAX Request for extension of the european patent (deleted)
RIN1 Information on inventor provided before grant (corrected)

Inventor name: FEISST, VAUGHAN, JOHN

Inventor name: HORLACHER, OLIVER

Inventor name: DUNBAR, PETER, RODERICK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20110520